BGH's tilt at Tourism Holdings has sparked more merger and acquisition speculation.

Fletcher Building, Spark and Ryman are potentially all on the radar.

Plus: Auckland Airport and Spark are back in favour with analysts at Morningstar.

Rising world bond yields are unsettling sharemarket investors.

An overhang on the stock is weighing on the retirement village operator's share price.

Analyst says risks in Fonterra-Bega legal tangle have been overstated.

Fisher and Paykel Healthcare will be the main event when it reports on May 28.

Mercury, Meridian and Manawa are likely to be hit hardest by the earlier drought.

New Zealand's sharemarket is in correction mode, but is faring better than others.

Fonterra's Mainland sale process continues despite a turbulent sharemarket.

Sharesies investors have opted to play safe during convulsions on world markets.

New Zealand shares suffered a poor first quarter, driven by sickly corporate earnings.

The change of Government in the United States has put ESG investing on the back foot.

Gold has hit a record high this week but is it a good investment?

Focus has turned to those companies who will benefit from this week's RBNZ rate cut.

The reporting season gets fully underway next week. Will there be green shoots?

There are some stark contrasts between the local index and other comparable markets.

F&P Healthcare's share price has held despite concerns about the US health sector.

Private equity is seen as a likely buyer for Fonterra's consumer business.

Plus: Sky TV gets a thumbs-up for its deal-making skills.

How will Infratil fund its ambitious plans for its Aussie data centre business?

F&P Healthcare recovers after a sell-off, and what's in store now for Cannasouth.

And will new car dealership Armstrong’s try listing on the sharemarket again?

The failed Ebos deal would have been a big bite for investors.

The NZSA has questioned the timeliness of PGW's disclosure.